January 6, 2026
Researchers with the UNC Institute for Global Health and Infectious Diseases, in collaboration with the UNC Lineberger and UNC Project-Malawi, found adults receiving rituximab as part of cancer treatment face a significantly higher risk of developing symptomatic malaria in an endemic region.
February 13, 2025
Part of UNC Project Malawi, the cancer program provides clinical care, pathology training and other services to the African nation. The program is entering the second phase of developing a low-cost cancer diagnosis method.
December 9, 2022
UNC Lineberger researchers will present the latest findings from studies and lead educational sessions at the 64th American Society of Hematology Annual Meeting in New Orleans, Dec. 10-13.
April 26, 2022
A newer, less expensive nanotechnology may make it possible to more accurately diagnose children with acute leukemia in lower income countries, according to findings by Thomas Alexander, MD, MPH, and colleagues.
July 23, 2021
Matthew Painschab, MD, and colleagues report that a five-drug combination chemotherapy provided curative benefit in people diagnosed with diffuse large B-cell lymphoma and is also a cost-effective option in Malawi.
August 25, 2020
A team of UNC researchers are partnering with colleagues at three institutions in Africa to study HIV-associated malignancies: Kaposi sarcoma, cervical cancer and lymphoma.
January 14, 2020
UNC Lineberger’s Christopher Dittus, DO, MPH, assistant professor of medicine at UNC School of Medicine, is the editor of a new book that provides a comprehensive review of how to diagnose and manage rare lymphomas, with a focus on novel treatment approaches. UNC Lineberger faculty and trainees contributed chapters to the volume. “Novel Therapeutics for …
